A Digital Home-Based Health Care Center for Remote Monitoring of Side Effects During Breast Cancer Therapy: Prospective, Single-Arm, Monocentric Feasibility Study
Adherence to scheduled remote visits was moderate, with nonadherence primarily attributed to device-related complications, which may have also affected the success rate of data transfer. Overall, patients considered remote monitoring useful and feasible. The prevalence of reported adverse events was comparable to existing literature, suggesting clinical potential. This initial feasibility study highlights the potential of the DHHC.
Authors
- Bernhard Volz
- Carolin C. Hack (ORCID: https://orcid.org/0000-0002-2426-7020)
- Matthias Ruebner (ORCID: https://orcid.org/0000-0002-2408-1138)
- Lena A. Wurmthaler
- Hanna Huebner (ORCID: https://orcid.org/0000-0001-6889-1493)
- Peter A. Fasching (ORCID: https://orcid.org/0000-0003-4885-8471)
- Juergen Geck (ORCID: https://orcid.org/0000-0002-8198-1992)
- Felix Heindl (ORCID: https://orcid.org/0000-0002-5484-2575)
- Matthias W. Beckmann (ORCID: https://orcid.org/0000-0002-8441-693X)
- Sabrina Uhrig
- Chloë Goossens (ORCID: https://orcid.org/0009-0009-2809-8082)
- Katharina Seitz (ORCID: https://orcid.org/0000-0002-2638-2655)
- Alexander Mocker
- Annika Krückel (ORCID: https://orcid.org/0009-0007-3298-9238)
- EA Roth
- Mathias Ernst (ORCID: https://orcid.org/0000-0003-1096-4316)
- Milena Limpert
- Manuel Hörner (ORCID: https://orcid.org/0000-0001-6934-992X)
- Philipp Kreis
- Maximilian Kallert
Institutions
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Universitätsklinikum Erlangen (DE)
- Georg Simon Ohm University of Applied Sciences Nuremberg (DE)
- Comprehensive Cancer Center Erlangen (DE)
Publication Details
- Journal
- JMIR Cancer
- Published
- 2025-05-02
- DOI
- https://doi.org/10.2196/64083
- Citations
- 2
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 3.04